Godavari Biorefineries FY26 Profit Rs 3.5 Crore, Turnaround From Loss

AGRICULTURE
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Godavari Biorefineries FY26 Profit Rs 3.5 Crore, Turnaround From Loss
Overview

Godavari Biorefineries reported a profit of Rs 3.5 crore for FY26, marking a turnaround from a loss in the previous year. The company's Q4 profit stood at Rs 52.9 crore. A new grain-based distillery is expected to be commissioned by June 2026.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Godavari Biorefineries Achieves FY26 Profitability with Rs 3.5 Crore PAT

FY26 PAT: ₹3.5 crore
Q4 FY26 PAT: ₹52.9 crore

Reader Takeaway: Turnaround to profit despite regulatory price pressures, new distillery expansion on track.

What just happened

Godavari Biorefineries Limited announced its financial performance for the fiscal year 2026 (FY26) and the fourth quarter (Q4 FY26). The company reported a Profit After Tax (PAT) of ₹3.5 crore for FY26, signifying a crucial turnaround from a loss-making position in FY25. The fourth quarter also saw a strong performance with a PAT of ₹52.9 crore. Total income for FY26 rose by 6% to ₹2000.2 crore from ₹1886.9 crore in FY25. EBITDA improved to ₹139.3 crore from ₹120.3 crore. Finance costs were reduced by approximately 32% year-on-year to ₹49.1 crore, aided by a debt repayment of ₹240 crore in FY25.

Why this matters

The return to profitability is a significant positive for shareholders, demonstrating the company's ability to navigate margin pressures. The reduction in finance costs points to improved financial health through debt reduction. The company is also investing in future growth with a 200 KLPD grain-based distillery set for commissioning in June 2026.

The backstory

In FY25, the company incurred losses. This year's results show a recovery driven by improved operational leverage and disciplined finance cost management. The company operates across three main segments: Sugar, Ethanol, Co-gen (₹1383 crore revenue in FY26), Bio-based Chemical (₹578 crore), and Consumer Business (Jivana) (₹129 crore).

What changes now

The immediate focus shifts to the commissioning of the new grain-based distillery. Management is also looking to manifest improvements in the bio-based segment in FY27 after debottlenecking efforts. The company aims to sustain profitability despite external factors.

Risks to watch

Profitability remains susceptible to government-fixed sugarcane prices and Minimum Support Prices (MSPs) for sugar and ethanol, which have not kept pace with rising input costs. Geopolitical tensions have also led to increased logistics and freight costs, impacting the chemical segment.

Peer comparison

While specific peer financial data for FY26 is not provided in the filing, the company's performance, especially its profitability turnaround, will be a key point of comparison against other sugar and ethanol manufacturers in India. Companies in the bio-based chemical sector also face similar input cost and market disruption challenges.

Context metrics (time-bound)

  • FY26 PAT: ₹3.5 crore (vs. loss in FY25)
  • Q4 FY26 PAT: ₹52.9 crore
  • FY26 Total Income: ₹2000.2 crore (up 6% YoY)
  • FY26 EBITDA: ₹139.3 crore (up 15% YoY)
  • FY26 Finance Cost: ₹49.1 crore (down ~32% YoY)
  • FY25 Debt Repayment: ₹240 crore
  • New Distillery Commissioning: June 2026

What to track next

Investors should monitor the commissioning of the new grain-based distillery, any updates on government pricing policies for sugarcane, sugar, and ethanol, and the performance trajectory of the bio-based chemical segment.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.